Financial Statements · Financial Reporting
GeneCode AS
Official identifier 10362550Record date 31 Dec 2023
Report
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- AS
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 5 Apr 2024
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 6,019,328 |
| Balance sheet | Cash and cash equivalents | 640,267 |
| Balance sheet | Current assets | 848,038 |
| Balance sheet | Current liabilities | 945,857 |
| Balance sheet | Equity | 4,814,959 |
| Balance sheet | Share capital at nominal value | 75,600 |
| Balance sheet | Non-current assets | 5,171,290 |
| Balance sheet | Non-current liabilities | 258,512 |
| Balance sheet | Retained earnings (loss) from previous periods | 427,578 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -3,851 |
| Income statement scheme 1 | Labour costs | -130,883 |
| Income statement scheme 1 | Annual period profit / loss | 951,155 |
| Income statement scheme 1 | Operating profit (loss) | 995,277 |
| Income statement scheme 1 | Profit (loss) before income tax | 951,155 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 427,578 |
| Note: Labour costs | Employees | 3 |
| Note: Labour costs | Labour costs | 130,883 |
Linked company
Company: GeneCode AS